This inventor holds 2 USPTO granted patents. Top assignees: Smith Kline & French Laboratories Limited, Smithkline Beecham Corporation. Active years: 1985-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 1985-1998
Title: **Antonietta Rose Mastrocola: Innovating in Medicinal Chemistry**
Introduction
Antonietta Rose Mastrocola is a distinguished inventor based in Bala Cynwyd, Pennsylvania, with a remarkable track record of innovation in the field of medicinal chemistry. She holds two patents that reflect her contributions to cancer treatment and pharmacology.
Latest Patents
Mastrocola's most recent patents include a "Process for the preparation of certain 9-substituted camptothecins." This patent details a method for producing water-soluble camptothecin analogs, which are critical for inhibiting the growth of tumor cells that are sensitive to these compounds. Her other patent, titled "Synthesis of 2-pyridylalkylamines," presents a process for creating 2-pyridylalkylamines through the reaction of an alkali metal derivative of 2-methylpyridine with haloalkylamine. The resulting compounds serve as intermediates for the synthesis of substances exhibiting histamine H1- and H2-antagonist activities.
Career Highlights
Antonietta has had a significant impact in her field, working with renowned organizations such as SmithKline Beecham Corporation and Smith Kline & French Laboratories Limited. Her career has been marked by a commitment to advancing medicinal chemistry, focusing on developing effective therapeutic agents.
Collaborations
Throughout her career, Mastrocola has collaborated with notable professionals, including Patrick L. Burk and Joseph Marian Fortunak. These partnerships have likely enhanced her research capabilities and contributed to the successful development of her patented technologies.
Conclusion
Antonietta Rose Mastrocola's innovative work in medicinal chemistry continues to pave the way for advancements in cancer treatment and pharmacological research. Her contributions through her patents exemplify her commitment to improving patient outcomes and addressing significant medical challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile